Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetuximab Maintenance in RAS-wt Colorectal Cancer
NCT02071069Phase 2Unknown
- Start
- Jul 2013
- Primary completion
- May 2016
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of KL-140 in colorectal cancer (CRC). Status: unknown.
02
Drugs
KL-140
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT02071069.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02071069.